The next big shake-up in the GLP-1 market? (Part 1 of 3)
In part one of our series, I’m joined by Valeriia Simanovskaia, founder and CEO of BioBrokers, an independent capital markets and strategic advisory firm for life sciences. The post The next big shake-up in the GLP-1 market? (Part 1 of 3) appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission…
We haven't written up this one. Labiotech has the full story — the link below goes straight to it.
